1. Home
  2. DDI vs TRDA Comparison

DDI vs TRDA Comparison

Compare DDI & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleDown Interactive Co. Ltd. American Depository Shares

DDI

DoubleDown Interactive Co. Ltd. American Depository Shares

N/A

Current Price

$9.05

Market Cap

433.6M

Sector

Technology

ML Signal

N/A

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$12.76

Market Cap

438.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DDI
TRDA
Founded
2008
2016
Country
South Korea
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
433.6M
438.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
DDI
TRDA
Price
$9.05
$12.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$19.00
$20.00
AVG Volume (30 Days)
70.9K
169.3K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,421,000.00
Revenue This Year
$7.63
N/A
Revenue Next Year
$3.68
$21.02
P/E Ratio
$4.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.09
$4.93
52 Week High
$11.25
$12.33

Technical Indicators

Market Signals
Indicator
DDI
TRDA
Relative Strength Index (RSI) 57.18 69.52
Support Level $8.64 $9.59
Resistance Level $9.32 N/A
Average True Range (ATR) 0.31 0.72
MACD 0.03 0.14
Stochastic Oscillator 94.29 97.91

Price Performance

Historical Comparison
DDI
TRDA

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: